Списоклитературы
1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2021. Availablefrom: www.ginasthma.org.
2. Федеральные клинические рекомендации. Бронхиальнаяастма. РРО. РААКИ. СоюзпедиатровРоссии, 2021.114 с.
3. Reddel H.K., Taylor D.R., Bateman E.D. etal. AnofficialAmericanThoracicSociety/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice // Am. J. Respir. Crit. Care Med. 2009.Vol. 180.P. 59-99.
4. Geelhoed G.C., Landau L.I., Le Souef P.N. Evaluation of SaO2 as a predictor of outcome in 280 children presenting with acute asthma // Ann. Emerg. Med. 1994.Vol. 23.P. 1236-1241.
5. Atta J.A., Nunes M.P., Fonseca-Guedes C.H. et al. Patient and physician evaluation of the severity of acute asthma exacerbations // Braz. J. Med. Biol. Res. 2004.Vol. 37.P. 1321-1330.
6. Nowak R.M., Tomlanovich M.C., Sarkar D.D.et al. Arterial blood gases and pulmonary function testing in acute bronchial asthma. Predicting patient outcomes // JAMA. 1983.Vol. 249.P. 2043-2046.
7. Nair P., Milan S.J., Rowe B.H. Addition of intravenous aminophylline to inhaled beta(2)-agonists in adults with acute asthma. Cochrane Database Syst Rev, 2012; 12: CD002742.
8. Hasegawa T., Ishihara K., Takakura S. et al. Duration of systemic corticosteroids in the treatment of asthma exacerbation; a randomized study // Intern. Med. 2000.Vol. 39.P. 794-797.
9. Jones A.M., Munavvar M., Vail A. et al. Prospective, placebo-controlled trial of 5 vs 10 days of oral prednisolone in acute adult asthma // Respir Med. 2002.Vol. 96.P. 950-954.
10. Rodrigo G.J., Rodrigo C., Hall J.B. Acute asthma in adults: a review // Chest. 2004.Vol. 125.P. 1081-1102.
11. Chung K.F., Wenzel S.E., Brozek J.L. et al. International ERS/ATS Guidelines on Definition, Evaluation and Treatment of Severe Asthma // Eur.Respir. J. 2014. Vol. 43. P. 343-373.
12. Авдеев С.Н., Жестков А.В., Лещенко И.В. и др. Небулизированный будесонид при тяжелом обострении бронхиальной астмы: сравнение с системными стероидами. Мультицентровое рандомизированное контролируемое исследование // Пульмонология. 2006. № 4.С. 58-67.
13. Овчаренко С.И. и др. Небулайзерная терапия бронхолитиками и суспензией Пульмикорта® в лечении тяжелых обострений бронхиальной астмы // Пульмонология.2003. № 6. С. 75-83.
14. Ediger D., Coskun F., Kunt Uzaskan E. et al. Clinical effectiveness of nebulized budesonide in the treatment of acute asthma attacks // Tuberkuloz ve Toraks Dergisi. 2006.Vol. 54.P. 128-136.
15. Higenbottam et al. // BioDrugs. 2000.Vol. 14.P. 247-254.
16. Rowe B.H., Bretzlaff J.A., Bourdon C., Bota G.W., Camargo C.A., Jr. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev, 2000.N. 2.
17. FitzGerald J.M. Magnesium sulfate is effective for severe acute asthma treated in the emergency department // West. J. Med. 2000.Vol. 172.P. 96.
18. Gallegos-Solorzano M.C., Perez-Padilla R., Hernandez-Zenteno R.J. Usefulness of inhaled magnesium sulfate in the coadjuvant management of severe asthma crisis in an emergency department // Pulm. Pharmacol. Ther. 2010.Vol. 23.P. 432-437.
19. Rodrigo G.J., Castro-Rodriguez J.A. Heliox-driven beta2-agonists nebulization for children and adults with acute asthma: a systematic review with meta-analysis // Ann. Allergy Asthma Immunol. 2014.Vo. 112.P. 29-34.
20. Pozin N., Montesantos S., Katz I., Pichelin M.et al. Calculated ventilation and effort distribution as a measure of respiratory disease and Heliox effectiveness // J. Biomech. 2017 Jul 26.Vol. 60.P. 100-109. doi: 10.1016/j.jbiomech.2017.06.009. Epub 2017 Jun 23. PMID: 28688537.
21. Abramson M.J., Puy R.M., Weiner J.M. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev, 2010. CD001186.
22. Gupta D.A prospective randomized controlled trial on the efficacy of noninvasive ventilation in severe acute asthma // Respir. Care. 2010.Vol. 55.P. 536-543.
23. National Asthma Education and Prevebtion Program. Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. Clinical practice Guidelines. 2007. Report No.: 07-4051.
24. Georgopoulos D., Burchardi H. Ventilation strategies in adult patients with status asthmaticus // Eur. Respir. Mon. 1998.Vol. 3.P. 45-83.
25. Авдеев С.Н. Респираторная поддержка при астматическом статусе. Клинические рекоммендации. Бронхиальная астма у взрослых / под ред. А.Г. Чучалина. Москва: Атмосфера, 2002.С. 130-155.
26. Kuyper L.M., Pare P.D., Hogg J.C. etal. Characterization of airway plugging in fatal asthma // Am. J. Med. 2003.Vol. 115. N. 1.P. 6-11.
27. Edmonds M.L., Milan S.J., Brenner B.E., Camargo C.A. Jr, Rowe BH. Inhaled steroids for acute asthma following emergency department discharge. Cochrane Database Syst Rev, 2012 Dec 12.Vol. 12. N. 12. CD002316. doi: 10.1002/14651858.CD002316.pub2. PMID: 23235590; PMCID: PMC6513225.
28. Rowe B.H., Bota G.W., Fabris L.et al. Inhaled budesonide in addition to oral steroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial // JAMA. 1999.Vol. 281. N. 22.P. 2219-2226.
29. Schatz M., Rachelefsky G., Krishnan J.A. Follow-up after acute asthma episodes: what improves future outcomes? // Proc. Am. Thorac. Soc. 2009. Vol. 6. P. 386-393.